⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 11, 2026Cancer Biology and MedicineOpen Access

Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study

Junxu Wen Q-X Wang Xinrui Yu Liu Y Xiaoyan Yin Shanshan Li Heng Zhao Zhaoqin Huang Y Q Chen Xiangjiao Meng

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to evaluate the effectiveness of induction immunochemotherapy followed by radiotherapy in patients with limited-stage small cell lung cancer.
Multicenter study design focusing on patients with limited-stage small cell lung cancer.
Inclusion of induction immunochemotherapy with durvalumab followed by radiotherapy.
Assessment of overall survival as a primary endpoint.
Durvalumab significantly improved overall survival with P = 0.01.
Findings suggest enhanced treatment methods for limited-stage small cell lung cancer.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Multicenter trial demonstrates improved overall survival with induction immunochemotherapy in LS-SCLC, suggesting effective treatment options.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wen et al. (2026) studied this question.

synapsesocial.com/papers/6a056824a550a87e60a2091b https://doi.org/10.20892/j.issn.2095-3941.2025.0800

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Integration of ımmunotherapy in limited-stage small cell lung cancer: a review of the literatureHuman Clinical Trial · 2026 · 2 citations
2Pathologic Complete Response and Durable Progression-Free Survival Following Neoadjuvant Chemo-immunotherapy and Surgery for Stage IIIB Small Cell Lung Cancer: A Case ReportLate-Phase Clinical Trial · 2026
3Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited-stage small-cell lung cancer: A retrospective, multi-center, real-world study.2025 · 1 citations
4Durvalumab plus chemotherapy prior to chemoradiotherapy and followed by durvalumab as consolidation for patients with limited-stage small cell lung cancer (CONCUR study).Early-Phase Clinical Trial · 2026
5Durvalumab combined with concurrent chemoradiotherapy in patients with limited‐stage small cell lung cancer: A prospective, single‐arm, phase 2 clinical trialCohort Study · 2026 · 1 citations